301 related articles for article (PubMed ID: 17014950)
21. Duloxetine for management of stress urinary incontinence.
Guay DR
Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
[TBL] [Abstract][Full Text] [Related]
22. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
23. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
[No Abstract] [Full Text] [Related]
24. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
25. [Place of duloxetine in the treatment of stress urinary incontinence].
Rouprêt M; Richard F; Chartier-Kastler E
Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
[TBL] [Abstract][Full Text] [Related]
26. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
27. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Ayeleke RO; Hay-Smith EJ; Omar MI
Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
[TBL] [Abstract][Full Text] [Related]
28. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
[TBL] [Abstract][Full Text] [Related]
29. Safety and tolerability of duloxetine in women with stress urinary incontinence.
Oelke M; Roovers JP; Michel MC
BJOG; 2006 May; 113 Suppl 1():22-6. PubMed ID: 16529566
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
Cardozo L; Drutz HP; Baygani SK; Bump RC
Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
[TBL] [Abstract][Full Text] [Related]
33. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
[TBL] [Abstract][Full Text] [Related]
34. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
Alberti C
G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
[TBL] [Abstract][Full Text] [Related]
35. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
Schlenker B; Gratzke C; Reich O; Schorsch I; Seitz M; Stief CG
Eur Urol; 2006 Jun; 49(6):1075-8. PubMed ID: 16481094
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.
Brunenberg DE; Joore MA; Veraart CP; Berghmans BC; van der Vaart CH; Severens JL
Clin Ther; 2006 Apr; 28(4):604-18. PubMed ID: 16750472
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacotherapy of stress incontinence].
Jost WH; Marsalek P; Michel MC
Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
[TBL] [Abstract][Full Text] [Related]
38. The effect of duloxetine on female sexual functions in the treatment of stress incontinence.
Biyikoglu M; Kettas E; Sesli M; Senel S; Cayan S; Akbay E
Arch Gynecol Obstet; 2023 Sep; 308(3):1037-1042. PubMed ID: 37386151
[TBL] [Abstract][Full Text] [Related]
39. Innovations in pharmacotherapy for stress urinary incontinence.
Cannon TW; Yoshimura N; Chancellor MB
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
[TBL] [Abstract][Full Text] [Related]
40. [Stress incontinence in general practice].
Krankenpfl J; 2004; 42(7-10):228-9. PubMed ID: 15675390
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
